TW200463B - - Google Patents

Download PDF

Info

Publication number
TW200463B
TW200463B TW081101198A TW81101198A TW200463B TW 200463 B TW200463 B TW 200463B TW 081101198 A TW081101198 A TW 081101198A TW 81101198 A TW81101198 A TW 81101198A TW 200463 B TW200463 B TW 200463B
Authority
TW
Taiwan
Prior art keywords
station
page
compound
cns
ministry
Prior art date
Application number
TW081101198A
Other languages
English (en)
Chinese (zh)
Inventor
Kohlsdorfer Christian
Muller-Peddinghaus Reiner
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of TW200463B publication Critical patent/TW200463B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Earth Drilling (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW081101198A 1991-02-22 1992-02-19 TW200463B (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4105551A DE4105551A1 (de) 1991-02-22 1991-02-22 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
TW200463B true TW200463B (ja) 1993-02-21

Family

ID=6425643

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081101198A TW200463B (ja) 1991-02-22 1992-02-19

Country Status (20)

Country Link
EP (1) EP0499926B1 (ja)
JP (1) JPH0592957A (ja)
KR (1) KR920016424A (ja)
AT (1) ATE142623T1 (ja)
AU (1) AU641585B2 (ja)
CZ (1) CZ282723B6 (ja)
DE (2) DE4105551A1 (ja)
DK (1) DK0499926T3 (ja)
ES (1) ES2091958T3 (ja)
FI (1) FI920732A (ja)
GR (1) GR3021014T3 (ja)
HU (1) HUT67037A (ja)
IE (1) IE75728B1 (ja)
IL (1) IL101009A (ja)
MY (1) MY108459A (ja)
NZ (1) NZ241654A (ja)
PL (2) PL171026B1 (ja)
RU (1) RU2077532C1 (ja)
TW (1) TW200463B (ja)
ZA (1) ZA921268B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
TW232013B (ja) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
DE4301900A1 (de) * 1993-01-25 1994-07-28 Bayer Ag 2-Oxochinolin-1-yl-methylphenylessigsäurederivate
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries Ltd Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
US6867320B2 (en) 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
CA2547518A1 (en) 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3908298A1 (de) * 1989-03-14 1990-09-20 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-n,n'-sulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
GR3021014T3 (en) 1996-12-31
JPH0592957A (ja) 1993-04-16
KR920016424A (ko) 1992-09-24
RU2077532C1 (ru) 1997-04-20
PL293534A1 (en) 1992-10-05
ES2091958T3 (es) 1996-11-16
AU641585B2 (en) 1993-09-23
EP0499926B1 (de) 1996-09-11
HU9200582D0 (en) 1992-05-28
PL170726B1 (pl) 1997-01-31
EP0499926A1 (de) 1992-08-26
MY108459A (en) 1996-09-30
DK0499926T3 (ja) 1997-02-10
NZ241654A (en) 1994-11-25
CZ282723B6 (cs) 1997-09-17
AU1054292A (en) 1992-08-27
ATE142623T1 (de) 1996-09-15
IE75728B1 (en) 1997-09-24
FI920732A (fi) 1992-08-23
IL101009A (en) 1996-08-04
DE59207074D1 (de) 1996-10-17
DE4105551A1 (de) 1992-08-27
IL101009A0 (en) 1992-11-15
CS51492A3 (en) 1992-12-16
FI920732A0 (fi) 1992-02-20
HUT67037A (en) 1995-01-30
PL171026B1 (pl) 1997-02-28
IE920557A1 (en) 1992-08-26
ZA921268B (en) 1992-11-25

Similar Documents

Publication Publication Date Title
TW200463B (ja)
TW210998B (ja)
JP6423372B2 (ja) 強力なｒｏｃｋ１およびｒｏｃｋ２阻害剤としてのフェニルピラゾール誘導体
JP2018199698A (ja) 置換された５−フルオロ−１ｈ−ピラゾロピリジン類を製造するための方法
CN110536884A (zh) Mcl-1抑制剂的合成
AU2017382830A1 (en) Amine-substituted heterocyclic compounds as EHMT2 inhibitors and methods of use thereof
JPH0625134B2 (ja) 新規な複素環化合物
CA2724077A1 (en) Amide compound
EP2970123A1 (en) Salt of omecamtiv mecarbil and process for preparing salt
DK158346B (da) Analogifremgangsmaade til fremstilling af 4-amino-5-alkylsulfonyl-o-anisamid-derivater samt 2-methoxy-4-amino-5-alkylsulfonylbenzoesyrer til anvendelse som mellemprodukter ved fremgangsmaaden
JPS6056143B2 (ja) アミジン誘導体ならびにその製造法
US9440979B2 (en) Process for the preparation of pralatrexate
EA002907B1 (ru) Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos
PT2077996E (pt) Processo de purificação de montelucaste e seus sais de amina
CA2583920A1 (en) Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
CA2393650C (en) Novel 1,8-naphthyridin-2(1h)-one derivatives
CN110770242A (zh) 作为vanin抑制剂的杂芳族化合物
TW446701B (en) Substituted quinolone derivatives and pharmaceuticals containing the same
TW202334163A (zh) 離胺酸乙醯基轉移酶6a (kat6a)抑制劑及其用途
EP3551613A1 (en) Compounds and pharmaceutical compositions for modulating sgk activity, and methods thereof
SU1039442A3 (ru) Способ получени производных фенилпиперазина
HU195075B (en) Bactericide composition containing 1-cyclopropyl-4-oxo-6-halogeno-3-quinoline-carboxylic acid derivative as active component
TWI245767B (en) Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo -(4.3.0)nonan-8-y1)6-fluoro-1,4-dihydro-oxo-3-quinolinecarboxylic acid
CN105732660B (zh) 左氧氟沙星中间体的制备方法
CN106831768A (zh) 一种2,6‑二氯吡啶[3,4‑b]吡嗪的合成方法